Fellowship · Rochester, MN
Sponsored by Mayo Clinic College of Medicine and Science
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 2022 · 4,889 citations · Shannon Dunlay
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Journal of the American College of Cardiology · 2022 · 2,444 citations · Shannon Dunlay
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
The New England journal of medicine · 2025 · 748 citations · Barry Borlaug
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
The New England journal of medicine · 2023 · 1,343 citations · Barry Borlaug
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.
Journal of cardiac failure · 2025 · 364 citations · Shannon Dunlay
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
The New England journal of medicine · 2024 · 601 citations ·
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 2022 · 873 citations · Shannon Dunlay
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Journal of the American College of Cardiology · 2022 · 834 citations · Shannon Dunlay